Surge Therapeutics Inc. landed $26 million in funding through a series A fundraising round to accelerate development of its intraoperative immunotherapy hydrogel.
PT Etana Biotechnologies Indonesia secured a series B financing of undisclosed value, led by Chinese investors that include Jack Ma’s Yunfeng Capital and Highlight Capital. The funds will be used to strengthen the company's pipeline and to expand its local manufacturing capacity.
Eye diseases specialist Oculis SA is set to add $200 million to its balance sheet by merging with the European Biotech Acquisition Corp., a special purpose acquisition company (SPAC) formed to invest in the European life sciences industry.
Med-tech firms raising money in public or private financings, including: Advanced Oncotherapy, Axis Spine Technologies, Ossio, Prenuvo, Ra Medical Systems, Viome Life Sciences.
Matchpoint Therapeutics Inc. has launched with $100 million in financing to research drugs based on covalent chemistry targeting inflammatory diseases, aiming to offer more patient-friendly oral alternatives to the biologic injections that dominate the field.
RSS
